Metabolism of a novel hypnotic, N³-phenacyluridine, and hypnotic and sedative activities of its enantiomer metabolites in mouse

References

• BAUMANN, P. and PRELOG, V., 1958, Reaktionen mit mikroorganismen. Die stereospezifische reduktion von stereoisomeren dekalindonen-(1,4). Helvetica Chimica Acta, 41, 2362–2379.
   Google Scholar
• BILLINGS, R. E., WHITAKER, G. W. and MCMAHON, R. E., 1980, The streoselective enzymic reduction of the synthetic 9-ketocannabinoid, nabilone, in vivo, in isolated liver cells and in liver homogenate. Xenobiotica, 10, 33–36.
   PubMed Web of Science ®Google Scholar
• GAL, J., DEVrro, D. and HARPER, T. W., 1981, GAS-chromatographic resolution of enantiomeric secondary alcohols. Stereoselective reductive metabolism of ketone in rabbit-liver cytosol. Drug Metabolism and Disposition, 9, 557–560.
   PubMed Web of Science ®Google Scholar
• HALEY, T. J. and McCoRmicK, W. G., 1957, Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse. British Journal of Pharmacology, 12, 12–15.
   PubMed Web of Science ®Google Scholar
• HONDA K., KOMODA, Y., NISHIDA, S., NAGASAKI, H., HIGASHI, A., UCHIZONO, K. and INouE, S., 1984, Uridine as an active component of sleep-promoting substance: its effects on nocturnal sleep in rats. Neuroscience Research, 1,243–252.
   Google Scholar
• IMAMURA Y., KopmA, Y. and ICHIBAGASE, H., 1985, Effect of simultaneous administration of drugs on absorption and excretion. XIX. Binding of acetohexamide and its major metabolite, ( - )-hydroxyhexamide, to human serum albumin. Chemical and Pharmaceutical Bulletin, 33, 1281–1284.
   Google Scholar
• INouE S., HONDA, K., KOMODA, Y., UCHIZONO, K., UENO, R. and HAYAISHI, O., 1984, Differential sleep-promoting effects of five sleep substances nocturnally infused in unrestrained rats. Proceeding of the National Academy of Sciences, USA, 81, 6240–6244.
   PubMedGoogle Scholar
• KIMURA, T., KUZE, J., WATANABE, K., KONDO, S., Ho, I. K. and YAMAMOTO, I., 1996, N3 - Phenacyluridine, a novel hypnotic compound, interacts with the benzodiazepine receptor. European Journal of Pharmacology, 311, 265–269.
   PubMedGoogle Scholar
• KIMURA T., WATANABE, K., TATEOKA, Y., KONDO, S., Ho, I. K. and YAMAMOTO, I., 1993, Preparation and pharmacological evaluation of N3-substitute1 thymidine derivatives as central depressants. Chemical and Pharmaceutical Bulletin, 41, 1180–1182.
   Google Scholar
• KIMURA T., YAMAMOTO, I., WATANABE, K., TATEOKA, Y. and Ho, I. K., 1991, In vivo and in vitro metabolic studies of N3-benzyluridine which exhibits hypnotic activity in mice. Research Communications in Chemical Pathology and Pharmacology, 71,27–48.
   Google Scholar
• KOMODA Y., ISHIKAWA, M., NAGASAKI, H., IRIKI, M., HONDA, K., INouE, S., HIGASHI, A. and UCHIZONO K, 1983, Uridine, a sleep-promoting substance from brainstems of sleep-deprived rats. Biomedical Research, 4, 223–228.
   Google Scholar
• KOSHIGAMI, M., WATANABE, K., KIMURA, T. and YAMAMOTO, I., 1991, Central depressant effects of N3-substituted 6-azauridines in mice. Chemical and Pharmaceutical Bulletin, 39, 25 97–25 99.
   Google Scholar
• KROOTH, R. S., HSIAO, W. L. and LAM, G. F. M., 1978, Effects of natural pyrimidines and of certain related compounds on the spontaneous activity of the mouse. Journal of Pharmacology and Experimental Therapeutics, 207, 504–514.
   PubMedGoogle Scholar
• MCMAHON, R. E., MARSHALL, F. J. and GULP, H. W., 1965, The nature of the metabolites of acetohexamide in the rat and in the human. Journal of Pharmacology and Experimental Therapeutics, 149, 272–279.
   PubMed Web of Science ®Google Scholar
• ROBERTS, C. A., 1973, Anticonvulsant effects of uridine: comparative analysis of Metrazol and penicillin induced foci. Brain Research, 55, 291–308.
   PubMed Web of Science ®Google Scholar
• MORELAND, T. A. and HEWICK, D. S., 1975, Studies on a ketone reductase in human and rat liver and kidney soluble faction using warfarin as a substrate. Biochemical Pharmacology, 24, 1953–1957.
   PubMed Web of Science ®Google Scholar
• TANAKA, Y., NISHIKAWA, Y. and HAYASHI, R., 1983, Species differences in metabolism of sodium 244-(2-oxocyclopentylmethyl)-phenyl]propionat dihydrate (loxoprofen sodium), a new anti-inflammatory agent. Chemical and Pharmaceutical Bulletin, 31, 3656–3664.
   PubMedGoogle Scholar
• YAMAMOTO, I., KIMURA, T., TATEOKA, Y., WATANABE, K. and Ho, I. K., 1985, N3-Benzyluridine exerts hypnotic activity in mice. Chemical and Pharmaceutical Bulletin, 33, 4088–4090.
   PubMed Web of Science ®Google Scholar
• YAMAMOTO, I., KIMURA, T., TATEOKA, Y., WATANABE, K. and Ho, I. K., 1986, Central depressant activities of N3-allyluridine and N3-allylthymidine. Research Communications in Chemical Pathology and Pharmacology, 52, 321–332.
   PubMedGoogle Scholar
• YAMAMOTO I., KIMURA, T., TATEOKA, Y., WATANABE, K. and Ho, I. K., 1987a, N-Substituted oxopyrimidines and nucleosides: structure-activity relationship for hypnotic activity as central nervous system depressant Journal of Medicinal Chemistry, 30, 2227–2231.
   Google Scholar
• YAMAMOTO, I., KIMURA, T., TATEOKA, Y., WATANABE, K. and Ho, I. K., 1987b, Hypnotic activity of N3-benzylthymidine on mice. Life Sciences, 41, 2791–2797.
   PubMedGoogle Scholar
• YAMAMOTO, I., KIMURA, T., WATANABE, K., TATEOKA, Y. and Ho, I. K., 1990, Action mechanism for hypnotic activity of N3-benzyluridine and related compounds. In S. Inoue and J. M. Krueger (eds), Endogenous Sleep Factors (The Netherlands: SPB Academic Publishing by), pp. 133–142.
   Google Scholar
• YAMAMOTO, I., KUZE, J., KIMURA, T., WATANABE, K., KONDO, S. and Ho, I. K., 1994, The potent depressant effects of N3-phenacyluridine in mice. Biological and Pharmaceutical Bulletin, 17, 514–516.
   PubMedGoogle Scholar